Internal Medicine, Endocrinology, Diabetes, & Metabolism · Chicago, IL
NPI
1083976187
Since 2012
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
5841 S Maryland Ave
Chicago, IL, 60637
Phone (888) 824-0200
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
2,219 services
Medicare patients, 2024
1,004
Average age 74
Drug cost, 2024
$1.2M
959 prescriptions
Company payments, 2025
$170
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajesh K Jain was code 77080 (standard x-ray), 382 times for 382 patients. In total Rajesh K Jain billed 2,219 services in 26 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 77080 Standard X-ray | Facility | 382 | 382 | $10.30 | $3,933 |
| 99214 Office E&M - Established | Facility | 227 | 224 | $76.78 | $17K |
| 77080 Standard X-ray | Office | 219 | 219 | $42.59 | $9,328 |
| 99214 Office E&M - Established | Office | 140 | 131 | $100.81 | $14K |
| 77081 Standard X-ray | Facility | 126 | 126 | $10.31 | $1,300 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 113 | 111 | $13.76 | $1,554 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 90 | 85 | $12.84 | $1,155 |
| 99204 Office E&M - New | Office | 48 | 48 | $129.63 | $6,222 |
| 99222 Hospital E&M - Initial | Facility | 34 | 34 | $116.63 | $3,966 |
| 36415 Venipuncture Blood Collection | Office | 22 | 18 | $8.65 | $190 |
| 99215 Office E&M - Established | Office | 15 | 14 | $160.84 | $2,413 |
By year: 2022 $59K for 1,622 services; 2023 $78K for 2,366 services; 2024 $81K for 2,219 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 22 | 18 | $8.65 | $190 |
Medicare prescription drug claims, 2024
In 2024, the drug Rajesh K Jain prescribed most often to Medicare patients was Alendronate Sodium, with 145 prescriptions and refills. In total Rajesh K Jain wrote 959 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alendronate Sodium Generic | 145 | 391 | 55 | $1,384 |
| Levothyroxine Sodium Generic | 91 | 261 | 28 | $1,107 |
| Dexamethasone Generic | 60 | 60 | 50 | $114 |
| Forteo Teriparatide | 46 | 67 | Under 11 | $243K |
| Teriparatide Generic | 41 | 51 | Under 11 | $113K |
| Ozempic Semaglutide | 35 | 47 | Under 11 | $41K |
| Atorvastatin Calcium Generic | 34 | 78 | 11 | $163 |
| Synthroid Levothyroxine Sodium | 32 | 94 | Under 11 | $1,359 |
| Mounjaro Tirzepatide | 28 | 32 | Under 11 | $32K |
| Methimazole Generic | 26 | 78 | Under 11 | $733 |
| Metformin Hcl Er Metformin Hcl | 25 | 49 | Under 11 | $160 |
| Crysvita Burosumab-Twza | 22 | 22 | Under 11 | $576K |
| Tymlos Abaloparatide | 18 | 30 | Under 11 | $75K |
| Hydrochlorothiazide Generic | 14 | 42 | Under 11 | $98.84 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 13 | 38 | Under 11 | $1,029 |
Brand drugs: 330 claims; generic drugs: 537 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajesh K Jain $170 ($170 in general payments such as food, travel and fees) from 4 companies. The largest payer was Stryker Corporation with $114.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.